Press Briefing : MSF-DNDi joint briefing on latest text of WHO Pandemic Agreement


The latest draft of the Pandemic Agreement was released publicly last Friday after two years of discussions coordinated by the Intergovernmental Negotiating Body (INB) under the ambit of the WHO. The next round of discussions will start on April 29, with the aim to present a final text to be adopted by Member States during the World Health Assembly, which begins on 27 May.

Having witnessed first-hand the catastrophic impact of inequitable access to lifesaving health tools during multiple outbreaks and global health emergencies including the COVID-19 pandemic, Médecins Sans Frontières (MSF) and the Drugs for Neglected Diseases initiative (DNDi) will be hosting a press briefing to share our reflections and comments on the latest draft of the Pandemic Agreement, from the perspectives of ensuring equitable access to lifesaving medical products by people in future global health emergencies.

We are inviting you to a closed technical press briefing on Wednesday 24 April at 2pm CET, during which experts from our organizations will present their analysis of the recently released draft and answer your questions:

· Ms Yuanqiong Hu, Senior Legal & Policy Advisor, MSF Access Campaign, will talk about provisions concerning stockpiling and equitable allocation, intellectual property and technology transfer, transparency and protection of population living in humanitarian settings.

· Ms Michelle Childs, Policy Advocacy Director, Drugs for Neglected Diseases initiative, will talk about the need to ensure that health products resulting from publicly funded pharmaceutical R&D should be equitably accessible and affordable.

To register, please simply send your confirmation to us via a reply to this email. We will then send you a link to connect to the briefing.

Best wishes,


Shailly Gupta - Senior Communications Advisor
Médecins Sans Frontières | Doctors Without Borders - Access Campaign
M: +41 79 203 13 02 |
Twitter: @shaillytweeting


Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About Médecins Sans Frontières (MSF) Access Campaign

In 1999, in the wake of Médecins Sans Frontières (MSF) being awarded the Nobel Peace Prize, MSF launched the Access Campaign. Its purpose has been to push for access to, and the development of life-saving and life prolonging medicines, diagnostic tests and vaccines for patients in MSF programmes and beyond.


Route de Ferney 140 P.O. Box 1224 CH-1211 Geneva 1, Switzerland

+41 79 203 13 02